Skip to main content

Post-IPO Equity Life Science Companies

Explore 105 life science startups that raised post-ipo equity funding. Access verified founder contact information and fundraising data.

Total Companies
105
Total Funding
$3.9B
Avg Funding
$155.9M
Cities
19

Export 105 Post-IPO Equity Life Science Companies

Get founder emails, funding data, and company details in one CSV

Start Free Trial

Recently Funded Companies

Export
Boston, United States
$200.0M
raised

Rapport Therapeutics is a clinical-stage biotechnology company that discovers and develops precision medicines for neurological disorders.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Reno, United States
$5.0M
raised

Medical Aesthetics, Longevity, Anti-Aging, Regenerative Medicine, Wound Care, Human Collagen

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

San Antonio, United States
$4.0M
raised

BioAffinity Technologies is a cancer diagnostics company that develops non-invasive, early-stage diagnostics to detect cancer and diseases.

Oct 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Oakville, Canada
$7.0M
raised

Cardiol Therapeutics develops innovative cannabidiol medicines for heart disease.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Carlsbad, United States
$400.0M
raised

Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs.

Sep 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 105 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Palo Alto, United States
$150.0M
raised

MapLight Therapeutics is a biopharma company that offers a platform designed to discover and develop therapeutics for brain disorders.

Aug 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Würzburg, Germany
$23.2M
raised

Pentixapharm develop PentixaFor and PentixaTher as a theranostic radiopharmaceutical pair.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Alameda, United States
$7.5M
raised

Scribe Therapeutics is a biotech company that develops and engineers new therapeutics based on CRISPR molecules.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Pittsburgh, United States
$972K
raised

Sharp Therapeutics is engaged in the development of biosensors for cellular biology research and high-throughput screening.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, Canada
$1.1M
raised

Publicly traded (RKV.V) company focused on the development of new cancer treatments based on novel DNA-damage response technologies.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 105 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
San Diego, United States
$632.5M
raised

Erasca is a developer of oncology drugs intended to provide precision oncology options.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

London, United Kingdom
$3.3M
raised

Virax Biolabs is a biotechnology company focusing on the prevention, detection, and diagnosis of viral diseases.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Palo Alto, United States
$1.0B
raised

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Jul 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Vancouver, United States
$100.0M
raised

Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Dallas, United States
$200.0M
raised

Taysha Gene Therapies develops treatments to eradicate severe and life-threatening monogenic diseases of the central nervous system.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 105 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Piscataway, United States
$226.0M
raised

Legend Biotech is a biopharmaceutical company that develops and commercializes novel cell therapies for oncology.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boston, United States
$57.5M
raised

SOPHiA GENETICS is a biotechnology firm that aims to support healthcare professionals by maximizing the power of data-driven medicine.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Ready to Reach These Founders?

Get verified contact info for decision-makers at 105 funded startups

41,000+ verified emails
Unlimited exports
No credit card required
Reykjavík, Iceland
$165.0M
raised

Alvotech is a biotechnology company that specializes in making biosimilars to create biologic medicines.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Brisbane, Australia
$3.5M
raised

Microba Life Sciences is a precision microbiome science company powering medical innovation to transform human health.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Cambridge, United States
$75.0M
raised

Parabilis Medicines is a Grupo Bugio is a biopharmaceutical firm that specializes in creating medicines.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Boulder, United States
$460.0M
raised

Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Markham, Canada
$2.5M
raised

Edesa develops treatments for dermatological and anorectal diseases. Edesa merged with Stellar Biotechnologies in 2019.

Jun 2026
Post-IPO Equity

Founder Contacts

41,000+ verified contacts

Showing 1 to 25 of 105 companies

Ready to Connect with Post-IPO Equity Life Science Startups?

Get verified founder emails, funding details, and company data for 105 post-ipo equity life science companies.

Get Started - Access Contact Information

Join thousands of sales teams, investors, and service providers using VCBacked